Yao Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

African American

Nlrp Inflammasome

Endoplasmic Reticulum Stress

Top Venues

Oxidative medicine and cellular longevity

Phytotherapy research : PTR

BioMed research international

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Ke-Jia Zhang, MiaoMiao Li, Kaiwen Yin, Minjie Wang, Qiuchi Dong, Zilan Miao, Yubo Guan, Qi Wu, Yao Zhou
Hyperoside mediates protection from diabetes kidney disease by regulating ROS-ERK signaling pathway and pyroptosis. Phytotherapy research : PTR (2023)
Guo-Wei Qin, Tong-Tong Xu, Xiang-Wei Lv, Shi-Min Jiang, Ke-Jia Zhang, Ming Xu, Lu Fu, Qi Wu, Yao Zhou
Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Wei-Kun Zhao, Yao Zhou, Tong-Tong Xu, Qi Wu
Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury. Oxidative medicine and cellular longevity 2021 (2021)
Ke-Jia Zhang, Qi Wu, Shi-Min Jiang, Lei Ding, Chao-Xia Liu, Ming Xu, Ying Wang, Yao Zhou, Li Li
Pyroptosis: A New Frontier in Kidney Diseases. Oxidative medicine and cellular longevity 2021 (2021)
Qi Wu, Ke-Jia Zhang, Shi-Min Jiang, Lu Fu, Yue Shi, Ru-Bin Tan, Jie Cui, Yao Zhou
p53: A Key Protein That Regulates Pulmonary Fibrosis. Oxidative medicine and cellular longevity 2020 (2020)
Qi Wu, Yong Xu, Ke-Jia Zhang, Shi-Min Jiang, Yao Zhou, Ying Zhao
A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis. BioMed research international 2020 (2020)